Cell Culture Industry

The global cell culture market was valued at approximately USD 16.59 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 11.32% from 2023 to 2030. This growth is largely driven by the increasing adoption of cell culture methods aimed at developing substrates that ensure the safe production of viral vaccines, alongside a rising global demand for advanced therapy medicinal products. Additionally, the emergence of innovative three-dimensional cell culture techniques, along with a growing necessity for these technologies in biopharmaceutical development and vaccine production, is anticipated to further propel market expansion throughout the forecast period.

The COVID-19 pandemic has created significant opportunities for researchers to explore the new virus, leading to the development of therapeutic and diagnostic tools. Many leading pharmaceutical and biotechnology firms have ramped up their research and development activities to create groundbreaking vaccines, therapies, and testing kits. This surge in R&D efforts has resulted in a notable increase in the demand for cell culture tools within research applications.

Moreover, the pandemic has intensified the need for novel cell-based models, organoids, and high-throughput screening platforms to support research and drug discovery initiatives. The urgent need to address the pandemic has also led to a heightened demand for bioreactors and culture systems specifically for vaccine production and drug testing applications. In response to this increased demand, numerous emerging and established companies have undertaken various initiatives to capitalize on the burgeoning need for cell culture products stemming from the challenges posed by the COVID-19 pandemic.

Gather more insights about the market drivers, restrains and growth of the Cell Culture Market

Product Segmentation Insights

In 2022, the consumables segment emerged as the dominant player, securing the largest market share of 57.44%. This segment is poised to experience substantial growth over the forecast period, driven by several key factors. The most prominent among these is the recurring demand for consumables, which are essential components used across a wide range of applications in research, diagnostics, and production processes. Unlike capital equipment, which requires a one-time investment, consumables are used frequently and need to be replenished regularly, leading to continuous market demand.

A significant factor further bolstering the growth of this segment is the increasing expenditure on research and development (R&D) by biotechnology and biopharmaceutical companies. These businesses are channeling more resources into the development of sophisticated biologics, such as monoclonal antibodies, vaccines, and other innovative treatments. Monoclonal antibodies, for example, have become critical in treating various diseases, including cancer and autoimmune disorders, driving the need for consumables in their development and production. Similarly, vaccines, particularly in the wake of the COVID-19 pandemic, have gained immense importance, spurring further investment in consumable products needed for their research and manufacturing.

The demand for consumables is expected to remain strong throughout the forecast period, with consistent usage across various sectors. The consumables segment is further classified into several subcategories, including reagents, media, and sera, each serving specific roles in cell culture and biological research. Reagents, for instance, are crucial for chemical reactions and biological assays, while sera and media are essential for maintaining cell cultures.

Within the consumables segment, the cell culture media subsegment stood out in 2022, accounting for the largest share of 42.76%. The robust growth in this area can be attributed to several converging factors. First, there has been a notable increase in R&D investments, particularly in life sciences industries such as biopharmaceuticals, where the need for cell culture media is critical for the development and production of biologics, including therapeutic proteins and vaccines.

Second, the overall expansion of the biotechnology industry has played a significant role in driving the demand for cell culture media. As more biotech companies focus on innovative solutions and novel therapies, the need for specialized media to support cell growth, reproduction, and preservation has grown significantly.

Furthermore, there has been a surge in interest in stem cell research, which is opening new avenues for therapeutic applications in regenerative medicine and tissue engineering. Stem cells are highly valued for their potential to develop into various types of cells, and this potential is being explored for treating a range of diseases. The use of stem cells in biotechnology research requires high-quality cell culture media, which further propels demand in this subsegment.

In summary, the consumables segment, particularly the cell culture media subsegment, is expected to experience sustained growth due to the increasing frequency of use, rising investments in R&D, and the expanding application of advanced biologics and stem cell research. This trend reflects the broader movement toward innovation in biotechnology and life sciences, with consumables playing a pivotal role in supporting ongoing research and product development.

Order a free sample PDF of the Cell Culture Market Intelligence Study, published by Grand View Research.